Correlation Between Innate Pharma and Genfit

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Genfit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Genfit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innate Pharma and Genfit, you can compare the effects of market volatilities on Innate Pharma and Genfit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Genfit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Genfit.

Diversification Opportunities for Innate Pharma and Genfit

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Innate and Genfit is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Genfit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genfit and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Genfit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genfit has no effect on the direction of Innate Pharma i.e., Innate Pharma and Genfit go up and down completely randomly.

Pair Corralation between Innate Pharma and Genfit

Given the investment horizon of 90 days Innate Pharma is expected to generate 1.87 times more return on investment than Genfit. However, Innate Pharma is 1.87 times more volatile than Genfit. It trades about 0.2 of its potential returns per unit of risk. Genfit is currently generating about -0.09 per unit of risk. If you would invest  176.00  in Innate Pharma on November 29, 2024 and sell it today you would earn a total of  50.00  from holding Innate Pharma or generate 28.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Innate Pharma  vs.  Genfit

 Performance 
       Timeline  
Innate Pharma 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Innate Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating technical indicators, Innate Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Genfit 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Genfit has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Innate Pharma and Genfit Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innate Pharma and Genfit

The main advantage of trading using opposite Innate Pharma and Genfit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Genfit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genfit will offset losses from the drop in Genfit's long position.
The idea behind Innate Pharma and Genfit pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators